Using our previously published gene expression profiling data, we compared t(4;11)-positive infant ALL samples which do and do not express the reciprocal AF4-MLL fusion product, as determined by PCR analysis. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.